Lo/Orval Birth Control Recall Lawsuits May Stem From Unwanted Pregnancies

Pfizer could face a number of product liability lawsuit following last week’s birth control recall, which was issued due to packaging errors that may put women at risk of unwanted pregnancy.

More than one million Lo/Orval and generic norgestrel birth control pills were recalled on January 31, after it was determined that some blister packs may contain the wrong number of pills and that the tablets may be out of sequence.

Pfizer has indicated that the birth control pill problems likely only affected a very small number of packages. However, the recall has caused substantial concern among users, who fear that they may become pregnant because they were not properly protected by the birth control pills they thought they were taking.

Did You Know?

AT&T Data Breach Impacts Millions of Customers

More than 73 million customers of AT&T may have had their names, addresses, phone numbers, Social Security numbers and other information released on the dark web due to a massive AT&T data breach. Lawsuits are being pursued to obtain financial compensation.

Learn More

Any users throughout the United States who become pregnant after taking the recalled Pfizer birth control pills may end up pursuing a lawsuit against Pfizer for the costs associated with the unwanted pregnancy and raising the child.

In many cases, the birth control may have been prescribed due to the high risks associated with pregnancy for certain women, including potential health problems the mother may face or a potential risk of birth malformations or defects that could caused by other medications the woman may be taking.

The Lo/Orval birth control problems were first noticed by a consumer who saw that a placebo pill had been included among the active ingredient pills in a blister package. Birth control pills are packaged so that active ingredient pills and placebo pills have different colors and follow a woman’s reproductive cycle.

Pfizer has warned that women who took the recalled birth control pills, even if they think nothing was wrong, should begin using a non-hormonal form of contraception immediately, return the recalled pills to their pharmacist and notify their doctor. Pfizer officials indicate there is no safety risk with the pills beyond the increased chance of a pregnancy.

In September, a similar recall was announced for birth control pills distributed by Qualitest Pharmaceitucals. In that incident, the blister packages were rotated 180 degrees during packaging, reversing the weekly tablet orientation. As evidenced by the response in social media and comments on this website, a number of women did indicate that they experienced unintended pregnancies as a result of those recalled birth control pills.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal
BioZorb Lawsuit Alleges Breast Tissue Marker Failed, Requiring Surgical Removal (Posted 2 days ago)

A BioZorb lawsuit has been filed by several breast cancer survivors after the BioZorb implants moved out of place and failed to dissolve int he body, requiring surgical removal.

Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October
Fairness Hearing For Philips CPAP Recall Medical Monitoring Settlement Set for October (Posted 2 days ago)

A U.S. District Court judge has scheduled a fairness hearing for October in order to determine whether final approval should be granted to a $25 million Philips CPAP recall settlement agreement, which would pay former users $25 million to pay for future medical monitoring needs.